On Monday's “Mad Money,” Jim Cramer said he remains bearish on Range Resources Corp. RRC saying natural gas is the weakest part of the petrol chain.
Cramer says although it's speculative, he is bullish on gene sequencing stock Guardant Health Inc GH.
He remains bullish on Berkshire Hathaway Inc. Class B (NYSE: BRK-B) and has been recommending the stock since the show began.
Seattle Genetics, Inc. SGEN is a buy, says Cramer.
Cramer says to steer clear of Zynerba Pharmaceuticals Inc ZYNE and if you want to play cannabinoids, GW Pharmaceuticals PLC-ADR GWPH is what he would buy.
Related Links:
'Halftime Report' Final Trades From July 16: American Airlines, JetBlue And More
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.